| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-09 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-09 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
1e-05 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0003 |